Back

Low-grade chronic inflammation is associated with cardiovascular risk factors but does not improve atherosclerosis stratification by the SCORE2 risk score

28 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Microvascular dysfunction in patients with chronic coronary syndrome Inflammation and Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Armanda Buffon

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

4 More presentations in this session

Presentation thumbnail
Impact of NIRS-IVUS-identified lipid-rich plaques on microvascular resistance reserve after PCI
Doctor H. Kusumoto (Takatsuki, JP)
Abstract Slides
Presentation thumbnail
Heterogeneity of coronary microvascular dysfunction: endotype-specific characteristics, symptoms, and outcomes.
Miss R. Verduijn (Heerlen, NL)
Abstract Slides
Presentation thumbnail
Histopathological correlates of coronary microvascular dysfunction in non-ischaemic heart failure with reduced or mildly reduced ejection fraction
Doctor H. Kadohara (Akashi, JP)
Abstract Slides
Presentation thumbnail
Predictive value of serum resolvin D1, absent in melanoma 2 and interleukin-1β levels for the presence and severity of coronary artery disease in chronic coronary syndrome
Doctor D. Ozturk Efe (Tekirdag, TR)
Abstract Slides

Access the full session

Session thumbnail
Microvascular dysfunction in patients with chronic coronary syndrome

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of vascular inflammation biomarkers over clinical risk factors for cardiovascular risk : a meta-analysis
17 April 2021
thumbnail
Congress Presentation
Relation between serum levels of long acting penicillin and the inflammatory markers: High sensitivity c-reactive protein and interleukin -6 in patients with chronic rheumatic heart disease
2 September 2019
thumbnail
Congress Presentation
Fitness is associated with lower inflammatory markers in obesity: The FATCOR study
28 August 2020
thumbnail
Congress Presentation
The impact of BMI into the ESC SCORE2 model on cardiovascular risk reclassification: results from a 20-year cohort study
3 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources